Pediatric Vaccines Market Research Report by Technology (Attenuated Live Viruses, Conjugates, and Inactivated Viruses), Vaccine Type, End User, Indication, State (Florida, Illinois, and Ohio) - United States Forecast to 2027 - Cumulative Impact of COVID-1

Pediatric Vaccines Market Research Report by Technology (Attenuated Live Viruses, Conjugates, and Inactivated Viruses), Vaccine Type, End User, Indication, State (Florida, Illinois, and Ohio) - United States Forecast to 2027 - Cumulative Impact of COVID-19

The United States Pediatric Vaccines Market size was estimated at USD 3,130.55 million in 2021 and expected to reach USD 3,663.13 million in 2022, and is projected to grow at a CAGR 13.35% to reach USD 6,641.29 million by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Pediatric Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technology, the market was studied across Attenuated Live Viruses, Conjugates, Inactivated Viruses, Polysaccharides, Recombinant, Subunits, and Toxoids.

Based on Vaccine Type, the market was studied across Monovalent and Multivalent.

Based on End User, the market was studied across Hospital, Pediatric Clinic, and Research Organization.

Based on Indication, the market was studied across Haemophilus Influenzae Type B, Hepatitis, Human papillomavirus (HPV), Measles, Meningitis A, Mumps, Pneumococcal Diseases, Polio, Rotaviruses, Rubella, Tetanus, and Yellow Fever.

Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pediatric Vaccines Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Pediatric Vaccines Market, including AstraZeneca PLC, CSL Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Merck Sharp & Dohme Corp., Mitsubishi Chemical Corporation, Novartis AG, Pfizer Inc., Sanofi S.A., and Serum Institute of India Pvt. Ltd..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Pediatric Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Pediatric Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Pediatric Vaccines Market?
4. What is the competitive strategic window for opportunities in the United States Pediatric Vaccines Market?
5. What are the technology trends and regulatory frameworks in the United States Pediatric Vaccines Market?
6. What is the market share of the leading vendors in the United States Pediatric Vaccines Market?
7. What modes and strategic moves are considered suitable for entering the United States Pediatric Vaccines Market?

Please Note: PDF & Excel + Online Access - 1 Year

Companies Mentioned

AstraZeneca PLC
CSL Limited
Eli Lilly and Company
GlaxoSmithKline PLC
Merck Sharp & Dohme Corp.
Mitsubishi Chemical Corporation
Novartis AG
Pfizer Inc.
Sanofi S.A.
Serum Institute of India Pvt. Ltd.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Pediatric Vaccines Market, by Technology
6.1. Introduction
6.2. Attenuated Live Viruses
6.3. Conjugates
6.4. Inactivated Viruses
6.5. Polysaccharides
6.6. Recombinant
6.7. Subunits
6.8. Toxoids
7. Pediatric Vaccines Market, by Vaccine Type
7.1. Introduction
7.2. Monovalent
7.3. Multivalent
8. Pediatric Vaccines Market, by End User
8.1. Introduction
8.2. Hospital
8.3. Pediatric Clinic
8.4. Research Organization
9. Pediatric Vaccines Market, by Indication
9.1. Introduction
9.2. Haemophilus Influenzae Type B
9.3. Hepatitis
9.4. Human papillomavirus (HPV)
9.5. Measles
9.6. Meningitis A
9.7. Mumps
9.8. Pneumococcal Diseases
9.9. Polio
9.10. Rotaviruses
9.11. Rubella
9.12. Tetanus
9.13. Yellow Fever
10. California Pediatric Vaccines Market
11. Florida Pediatric Vaccines Market
12. Illinois Pediatric Vaccines Market
13. New York Pediatric Vaccines Market
14. Ohio Pediatric Vaccines Market
15. Pennsylvania Pediatric Vaccines Market
16. Texas Pediatric Vaccines Market
17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion
18. Company Usability Profiles
18.1. AstraZeneca PLC
18.2. CSL Limited
18.3. Eli Lilly and Company
18.4. GlaxoSmithKline PLC
18.5. Merck Sharp & Dohme Corp.
18.6. Mitsubishi Chemical Corporation
18.7. Novartis AG
18.8. Pfizer Inc.
18.9. Sanofi S.A.
18.10. Serum Institute of India Pvt. Ltd.
19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings